Novel ASO therapeutic target designed against hyperlipidemia via PCSK9 knockdown

by Xinjian Yu, Kai Song
Published 2024-01-01

Reassessment of Reliability and Reproducibility for Triple-Negative Breast Cancer Subtyping

by Xinjian Yu, Yongjing Liu, Ming Chen
Published 2022-05-01

Fatty acid composition analyses of commercially important fish species from the Pearl River Estuary, China.

by Xiyang Zhang, Xi Ning, Xiaoxiao He, Xian Sun, Xinjian Yu, Yuanxiong Cheng, Ri-Qing Yu, Yuping Wu
Published 2020-01-01

Navigating relapsed hepatoblastoma: Predictive factors and surgical treatment strategy

by Andres F. Espinoza, Kalyani R. Patel, Priya B. Shetty, Richard S. Whitlock, Pavel Sumazin, Xinjian Yu, Stephen F. Sarabia, Martin Urbicain, Andras Heczey, Prakash Masand, Sarah E. Woodfield, Dolores H. López‐Terrada, Sanjeev A. Vasudevan
Published 2023-12-01

A novel full-human CD22-CAR T cell therapy with potent activity against CD22low B-ALL

by Yue Tan, Haodong Cai, Chuo Li, Biping Deng, Weiliang Song, Zhuojun Ling, Guang Hu, Yongkun Yang, Panpan Niu, Guangrong Meng, Wei Cheng, Jinlong Xu, Jiajia Duan, Zelin Wang, Xinjian Yu, Xiaoming Feng, Jianfeng Zhou, Jing Pan
Published 2021-04-01

Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblastic leukemia

by Yue Tan, Lingling Shan, Liping Zhao, Biping Deng, Zhuojun Ling, Yanlei Zhang, Shuixiu Peng, Jinlong Xu, Jiajia Duan, Zelin Wang, Xinjian Yu, Qinlong Zheng, Xiuwen Xu, Zhenglong Tian, Yibing Zhang, Jiecheng Zhang, Alex H. Chang, Xiaoming Feng, Jing Pan
Published 2023-04-01

Peripheral leukemia burden at time of apheresis negatively affects the clinical efficacy of CART19 in refractory or relapsed B-ALL

by Biping Deng, Jing Pan, Zhaoli Liu, Shuangyou Liu, Yunlong Chen, Xiaomin Qu, Yu'e Zhang, Yuehui Lin, Yanlei Zhang, Xinjian Yu, Zhongxin Zhang, Xuansha Niu, Rong Luan, Ming Ma, Xiaomei Li, Tingting Liu, Xi'ai Wu, Huan Niu, Alex H. Chang, Chunrong Tong
Published 2021-12-01